Canopy Growth Share Price (NASDAQ: CGC)

$1.41

▲

0.14

(11.02%)

Live

Last updated on August 26, 2025 at 12:40 AM IST

$₹

Check the interactive Canopy Growth Stock chart to analyse performance

Canopy Growth stock performance

as on August 26, 2025 at 12:40 AM IST

Today's Low:$1.35
Today's High:$1.44
$1.41
4.26%
Downside
Day's Volatility :5.92%
Upside
1.74%
52 Weeks Low:$0.77
52 Weeks High:$6.27
$1.41
45.39%
Downside
52 Weeks Volatility :87.71%
Upside
77.49%

Canopy Growth Stock Returns

Period	Canopy Growth Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	-25.29%	6.0%	0.0%
6 Months	-21.6%	-7.2%	0.0%
1 Year	-79.42%	-11.1%	0.0%
3 Years	-96.69%	5.5%	-10.0%

Canopy Growth Corporation Key Stats

Check Canopy Growth key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.27
Open	$1.25
Today's High	$1.44
Today's Low	$1.35
Market Capitalization	$338.8M
Today's Volume	$17.1M
52 Week High	$6.265
52 Week Low	$0.77
Revenue TTM	$274.9M
EBITDA	$-7.9M
Earnings Per Share (EPS)	$-3.03
Profit Margin	-186.42%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-101.08%

Stock Returns calculator for Canopy Growth Stock including INR - Dollar returns

The Canopy Growth stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Canopy Growth investment value today

Current value as on today

₹27,187

Returns

₹72,813

(-72.81%)

Returns from Canopy Growth Stock

₹77,147 (-77.15%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Canopy Growth Stock

46%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Canopy Growth Stock from India on INDmoney has increased by 46% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Canopy Growth Corporation

Name
Holdings %
Name
Holdings %
Tidal Investments LLC.
1.87%
Millennium Management LLC
0.90%
Morgan Stanley - Brokerage Accounts
0.59%
Susquehanna International Group, LLP
0.54%
Goldman Sachs Group Inc
0.50%
Jane Street Group LLC
0.41%

Analyst Recommendation on Canopy Growth Stock

Rating

Trend

Sell

5%Buy

45%Hold

50%Sell

Based on 20 Wall street analysts offering stock ratings for Canopy Growth(by analysts ranked 0 to 5 stars)

Canopy Growth Share Price Target

What analysts predicted

Upside of 169.16%

Target:

$3.80

Current:

$1.41

Canopy Growth share price target is $3.80, a slight Upside of 169.16% compared to current price of $1.41 as per analysts' prediction.

Canopy Growth Stock Insights

Price Movement
In the last 7 days, CGC stock has moved down by -7.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 63.68M → 72.13M (in $), with an average increase of 11.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -219.51M → -41.52M (in $), with an average increase of 428.6% per quarter
CGC vs HLN (1 yr)
In the last 1 year, Canopy Growth Corporation has experienced a drawdown of -79.5%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 78.7%
CGC vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 55.4% return, outperforming this stock by 152.4%
Price to Sales
ForCGC every $1 of sales, investors are willing to pay $0.6, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Canopy Growth Corporation Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$286.5M	↑ 76.18%
Net Income	$-996.8M	↑ 107.05%
Net Profit Margin	-347.93%	↓ 51.87%

	FY21	Y/Y Change
Revenue	$434.8M	↑ 37.08%
Net Income	$-1.4B	↑ 25.77%
Net Profit Margin	-319.2%	↑ 28.73%

	FY22	Y/Y Change
Revenue	$375.9M	↓ 12.98%
Net Income	$-245.0M	↓ 82.23%
Net Profit Margin	-65.18%	↑ 254.02%

	FY23	Y/Y Change
Revenue	$243.4M	↓ 29.94%
Net Income	$-2.4B	↑ 957.32%
Net Profit Margin	-983.68%	↓ 918.5%

	FY24	Y/Y Change
Revenue	$219.5M	↓ 10.83%
Net Income	$-485.5M	↓ 79.95%
Net Profit Margin	-221.19%	↑ 762.49%

	FY25	Y/Y Change
Revenue	$186.3M	↓ 9.99%
Net Income	$-414.3M	↓ 9.52%
Net Profit Margin	-222.35%	↓ 1.16%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$53.8M	↓ 7.28%
Net Income	$-68.2M	↓ 57.41%
Net Profit Margin	-126.86%	↑ 149.3%

	Q2 FY24	Q/Q Change
Revenue	$48.3M	↓ 9.1%
Net Income	$-92.7M	↑ 37.6%
Net Profit Margin	-192.02%	↓ 65.16%

	Q3 FY24	Q/Q Change
Revenue	$46.4M	↓ 4.96%
Net Income	$-94.6M	↑ 0.81%
Net Profit Margin	-203.67%	↓ 11.65%

	Q4 FY24	Q/Q Change
Revenue	$74.7M	↑ 18.8%
Net Income	$-121.8M	↓ 4.9%
Net Profit Margin	-163.05%	↑ 40.62%

	Q1 FY25	Q/Q Change
Revenue	$44.4M	↓ 14.76%
Net Income	$-152.9M	↑ 80.21%
Net Profit Margin	-344.71%	↓ 181.66%

	Q2 FY25	Q/Q Change
Revenue	$72.1M	↑ 13.27%
Net Income	$-41.5M	↓ 81.08%
Net Profit Margin	-57.57%	↑ 287.14%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$-22.8M	↓ 135.63%

	FY21	Y/Y Change
Profit	$53.3M	↓ 311.34%

	FY22	Y/Y Change
Profit	$-60.3M	↓ 213.95%

	FY23	Y/Y Change
Profit	$-46.4M	↓ 16.74%

	FY24	Y/Y Change
Profit	$59.7M	↓ 227.32%

	FY25	Y/Y Change
Profit	$38.3M	↓ 32.0%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$6.1M	↓ 70.71%

	Q2 FY24	Q/Q Change
Profit	$12.4M	↑ 105.42%

	Q3 FY24	Q/Q Change
Profit	$11.7M	↓ 7.0%

	Q4 FY24	Q/Q Change
Profit	$18.1M	↑ 14.45%

	Q1 FY25	Q/Q Change
Profit	$3.1M	↓ 75.67%

	Q2 FY25	Q/Q Change
Profit	$18.0M	↑ 310.23%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$-555.1M	↑ 48.44%
Investing Cash Flow	$-249.8M	↓ 89.23%
Financing Cash Flow	$-41.1M	↓ 100.98%

	FY21	Y/Y Change
Operating Cash Flow	$-370.4M	↓ 39.72%
Investing Cash Flow	$-703.1M	↑ 154.31%
Financing Cash Flow	$1.0B	↓ 2312.64%

	FY22	Y/Y Change
Operating Cash Flow	$-431.3M	↑ 17.19%
Investing Cash Flow	$182.4M	↓ 126.11%
Financing Cash Flow	$-36.0M	↓ 103.6%

	FY23	Y/Y Change
Operating Cash Flow	$-407.3M	↑ 2.15%
Investing Cash Flow	$316.6M	↑ 87.76%
Financing Cash Flow	$-14.4M	↓ 56.75%

	FY24	Y/Y Change
Operating Cash Flow	$-208.3M	↓ 49.43%
Investing Cash Flow	$178.4M	↓ 44.25%
Financing Cash Flow	$-343.5M	↑ 2261.4%

	FY25	Y/Y Change
Operating Cash Flow	$-115.5M	↓ 41.21%
Investing Cash Flow	$-33.3M	↓ 119.78%
Financing Cash Flow	$103.6M	↓ 131.97%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-16.3M	↓ 32.27%
Investing Cash Flow	$29.2M	↓ 6562.19%
Financing Cash Flow	$6.3M	↓ 112.79%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-37.8M	↑ 134.73%
Investing Cash Flow	$-24.1M	↓ 183.65%
Financing Cash Flow	$77.2M	↑ 1148.97%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-39.8M	↑ 4.0%
Investing Cash Flow	$764.9K	↓ 103.14%
Financing Cash Flow	$65.7M	↓ 15.91%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-18.9M	↓ 49.93%
Investing Cash Flow	$-10.4M	↓ 1527.99%
Financing Cash Flow	$-21.1M	↓ 133.84%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-23.1M	↑ 22.94%
Investing Cash Flow	$-697.4K	↓ 93.23%
Financing Cash Flow	$-11.1M	↓ 46.98%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-10.3M	↓ 68.82%
Investing Cash Flow	$-705.0K	↓ 29.57%
Financing Cash Flow	$25.5M	↓ 259.54%

Canopy Growth Technicals Summary

Sell

Neutral

Buy

Canopy Growth is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Canopy Growth Corporation Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Canopy Growth Corporation	16.51%	-21.6%	-79.42%	-96.69%	-99.23%
Haleon Plc Spon Ads	1.24%	-3.25%	-0.51%	57.62%	32.52%
United Therapeutics Corporation	4.73%	-12.84%	-9.93%	45.02%	75.59%
Zoetis Inc.	3.89%	-5.26%	-13.74%	-2.05%	-1.97%
Neurocrine Biosciences Inc.	1.29%	13.7%	-11.06%	29.14%	21.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Canopy Growth Corporation	NA	NA	NA	-3.4	-1.01	-0.03	NA	2.38
Haleon Plc Spon Ads	21.82	21.82	3.16	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.18	12.18	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.96	26.96	2.54	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	39.95	39.95	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Canopy Growth Corporation	Sell	$338.8M	-99.23%	NA	-186.42%
Haleon Plc Spon Ads	Buy	$44.2B	32.52%	21.82	13.81%
United Therapeutics Corporation	Buy	$14.1B	75.59%	12.18	40.36%
Zoetis Inc.	Buy	$69.4B	-1.97%	26.96	27.83%
Neurocrine Biosciences Inc.	Buy	$13.4B	21.15%	39.95	13.88%

About Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Organization	Canopy Growth
Employees	960
CEO	Mr. Luc Mongeau
Industry	Process Industries

Key Management of Canopy Growth Corporation

Name	Title
Mr. Luc Mongeau	CEO & Director
Dr. Christelle Gedeon L.L.B., Ph.D.	Chief Legal Officer & Corporate Secretary
Mr. Thomas Carlton Stewart CPA	Interim Chief Financial Officer
Mr. Bryan Murphy	Senior Vice President of Operations
Ms. Jenny Brewer	Chief Human Resources Officer
Jason Green	Head of Agriculture - Hemp Division
Mr. Jurgen Bickel	MD and Co-Founder of STORZ & BICKEL GmbH
Mr. Andrew Bevan	Senior Vice President of Medical Sales
Mr. Miles Worne	Managing Director of European Markets
Mr. Tyler Burns	Director of Investor Relations

Important FAQs about investing in CGC Stock from India :

What is Canopy Growth share price today?

Canopy Growth share price today is $1.41 as on August 26, 2025 at 12:40 AM IST. Canopy Growth share today touched a day high of $1.44 and a low of $1.35.

What is the 52 week high and 52 week low for Canopy Growth share?

Canopy Growth share touched a 52 week high of $6.27 and a 52 week low of $0.77. Canopy Growth stock price today i.e. August 26, 2025 at 12:40 AM IST is trending at $1.41, lower by 77.49% versus the 52 week high.

How to invest in Canopy Growth Stock (CGC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Canopy Growth on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Canopy Growth Shares that will get you 1.0638 shares as per Canopy Growth share price of $1.41 per share as on August 26, 2025 at 12:40 AM IST.

What is the minimum amount required to buy Canopy Growth Stock (CGC) from India?

Indian investors can start investing in Canopy Growth (CGC) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Canopy Growth stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Canopy Growth share’s latest price of $1.41 as on August 26, 2025 at 12:40 AM IST, you will get 7.0922 shares of Canopy Growth. Learn more about fractional shares .

What are the returns that Canopy Growth has given to Indian investors in the last 5 years?

Canopy Growth stock has given -99.23% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?